Governance IXICO plc

IXI

GB00BFXR4C20

Biotechnology & Medical Research

Market Closed - London S.E. Other stock markets 11:35:16 2026-05-08 EDT			5-day change	1st Jan Change
6.625 ^GBX	-3.64%		-3.64%	-43.62%

04-21	EARNINGS AND TRADING: Mpac swings to loss; Gear4music sales rise 30%	AN
04-21	Ixico plc Provides Earnings Guidance for the First Half Ended 31 March 2026	CI

Executive Committee: IXICO plc

Manager

Positions heldSince

Bram Goorden

53 year

Chief Executive Officer

2024-08-18

Grant Nash

50 year

Chief Operating Officer	2019-08-20
Director of Finance/CFO	2019-08-20
Corporate Secretary	2019-05-30

Robin Wolz

Chief Tech/Sci/R&D Officer

2020-12-31

Mark Austin

Chief Tech/Sci/R&D Officer

2025-05-31

Hannah Esfahanian

Human Resources Officer

2021-12-31

Anna-Maria Moseley

General Counsel

2019-12-31

Composition of the Board of Directors: IXICO plc

Director

CommitteesSince

Mark Warne

51 year

Chairman
Independent Dir/Board Member	2016-09-15

Dipti Amin

62 year

Compensation Committee
Audit Committee	2023-10-04
Compensation Committee Chair	2023-10-04

Katherine Rogers

60 year

Compensation Committee
Audit Committee Chair	2022-04-29

Bram Goorden

53 year

Director/Board Member

2024-08-18

Grant Nash

50 year

Director/Board Member

2019-08-20

Latest Appointments: IXICO plc

02-05	Ixico Names Chief Commercial Officer	MT
02-05	IXICO plc Appoints Tanya Voloshen as Chief Commercial Officer	CI
12-01	IXICO plc Announces Scientific Advisory Board Appointments, Effective December 1, 2025	CI
25-04-16	EARNINGS AND TRADING: HEIT changes tack and backs Foresight cash bid	AN
24-12-10	EARNINGS AND TRADING: Dianomi trading in line; Solid State profit dips	AN
24-08-05	Ixico names Bram Goorden as next chief executive officer	AN
24-08-05	Ixico Hires New CEO	MT

More news

Former Officers and Directors: IXICO plc

Insider

Positions held

SinceUntil

Giulio Cerroni

Director/Board Member	2017-02-05	2024-08-15
Chief Executive Officer	2017-02-05	2024-08-18

Charles Spicer

Director/Board Member	2013-10-13	2016-09-15
Chairman	2016-09-15	2023-12-31
Corporate Officer/Principal	2013-10-13	2016-01-28

John Bradshaw

Director/Board Member	2013-10-13	2022-04-29
Independent Dir/Board Member	2013-10-13	2022-04-29

Lammert Albers

Corporate Officer/Principal

2019-10-27

2021-12-31

John Hall

Corporate Officer/Principal

2013-10-14

2020-02-29

Conor Wolfson

Comptroller/Controller/Auditor	-	2019-05-30
Director of Finance/CFO	2018-12-10	2019-04-28

Susan Lowther

Director/Board Member	2014-09-30	2018-12-10
Director of Finance/CFO	2014-09-30	2018-12-10
Corporate Secretary	-	2018-12-10

Derek Lionel Glendon Hill

Director/Board Member	2013-10-14	2018-01-21
Chief Executive Officer	1995-11-27	2017-02-05
Founder	1995-11-27	2018-01-21
Corporate Officer/Principal	2017-05-21	2018-01-21

Kate McLeish

Chief Tech/Sci/R&D Officer

2004-12-31

2017-06-30

Janet Munro

Corporate Officer/Principal

2015-11-30

2017-05-31

Andrew Richards

Chairman	2008-12-31	2016-09-15
Independent Dir/Board Member	2008-12-31	2016-09-15

David Brister

Director/Board Member	2015-11-30	2016-09-15
Independent Dir/Board Member	2015-11-30	-

Kenneth M. Tubman

Corporate Officer/Principal

2015-11-30

Krish Ramakrisnan

Sales & Marketing

2014-03-30

Jane Whitrow

Chief Operating Officer	2013-10-14	-
Investor Relations Contact	2013-10-14	-
Corporate Secretary	2013-10-14	-

Timothy Sharpington

Director/Board Member	2013-10-14	-
Independent Dir/Board Member	2013-10-14	-

Michelle Lax

Chief Tech/Sci/R&D Officer

2011-12-31

Maina Bhaman

Director/Board Member

2009-12-31

Romina Oxborough

Chief Operating Officer

Age distribution of managers

Parity Men Women

Male	7
Female	4

Of which Executive Committee

Male	4
Female	2

Of which Directors

Male	4
Female	1

IXICO plc is a United Kingdom-based medical imaging advanced analytics company. The Company is engaged in delivering insights in neuroscience to help transform the advancement of investigational therapies for neurological diseases, such as Huntington's disease, Parkinson's disease and Alzheimer's disease. It advances medicine and human health by turning data into clinically meaningful information, providing new insights in neuroscience by supporting pharmaceutical companies across all phases of central nervous system (CNS) clinical research. Its services include the collection, analysis, management, and reporting on data generated in the course of a clinical study. Its data platforms include TrialTracker and Assessa. The TrialTracker platform provides a secure and compliant environment for the collection, analysis and interpretation of large image files and other data. Its neuroimaging biomarkers focus area includes Radiological Reads, Volumetric MRI, PET and SPECT, and Advanced MRI.

Employees

Sector

Biotechnology & Medical Research

Calendar

Earnings release - Q2 2026

More about the company